LENALIDOMIDE Devatis caps 7.5 mg 21 pce

7680685180100 CH-68518 L04AX04 07.16.4.

Reimbursement limitations:

LENALI.DE.09

LENALIDOMID DEVATIS en association avec l’ixazomib et la dexaméthasone
Après accord sur la prise en …

LENALIDOMIDE Devatis caps 7.5 mg 21 pce
LENALIDOMIDE Devatis caps 7.5 mg 21 pce
LENALIDOMIDE Devatis caps 7.5 mg 21 pce
1 / 3
google

Details

Product number
6851803
CPT
-
Packaging group
21
Unit
Kapsel(n)
Composition
lenalidomidum 7.5 mg, lactosum 60.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.612 mg, magnesii stearas, Kapselhülle: gelatina, titanii dioxidum, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula.

Articles (1)

Lenalidomid Devatis 7.5 mg, Hartkapseln
Kapseln
21
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/12/2022
Patient information leaflet
Français
14/12/2022
Patient information leaflet
Italien
14/12/2022
Professional SmPC
Allemand
14/12/2022
Professional SmPC
Français
14/12/2022
Professional SmPC
Italien
14/12/2022

Detailed composition

Substance Quantity Type Category
(N/A)
7.5 MG Substance Wirkstoff (Principe actif)
(N/A)
60.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.612 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 806.30
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/06/2024

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
68518
Drug name
Lenalidomid Devatis, Hartkapseln
Galenic form
KAHA
ATC Code
L04AX04
Authorization status
Z
Dispensation category
A
First authorization
12/01/2022
Authorization expiration date
11/01/2027
IT number
07.16.4.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
LENALIDOMIDE Devatis caps 7.5 mg 21 pce
Description (DE)
LENALIDOMID Devatis Kaps 7.5 mg 21 Stk
Market launch
12/01/2022
Narcotic (BTM)
No

Original drug

REVLIMID, Hartkapseln
CHF 2480.50
View original

Other packaging sizes

LENALIDOMIDE Devatis caps 2.5 mg blist 21 pce
21 KAP
View
LENALIDOMIDE Devatis caps 2.5 mg 21 pce
21 KAP
View
LENALIDOMIDE Devatis caps 5 mg blist 21 pce
21 KAP
View
LENALIDOMIDE Devatis caps 5 mg 21 pce
21 KAP
View
LENALIDOMIDE Devatis caps 7.5 mg blist 21 pce
21 KAP
View
LENALIDOMIDE Devatis caps 10 mg blist 21 pce
21 KAP
View
LENALIDOMIDE Devatis caps 10 mg 21 pce
21 KAP
View
LENALIDOMIDE Devatis caps 15 mg blist 21 pce
21 KAP
View
LENALIDOMIDE Devatis caps 15 mg 21 pce
21 KAP
View
LENALIDOMIDE Devatis caps 20 mg blist 21 pce
21 KAP
View